Quick Answer
Anika Therapeutics, Inc. reported Common Stock Shares Outstanding of 13.89 million shares for the year ending 2025.
- Anika Therapeutics, Inc. showed a decrease of -3.7% in Common Stock Shares Outstanding from 2024 to 2025.
- This data is from Anika Therapeutics, Inc.'s annual report (Form 10-K), filed with the SEC on March 3, 2026.
- XBRL data for this metric is available from 2010 to 2025 (16 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 16 years of available data (2010 to 2025), Anika Therapeutics, Inc.'s Common Stock Shares Outstanding has grown by 3.0%.
- Historical annual values: Fiscal year 2025: 13.89 million shares | Fiscal year 2024: 14.42 million shares | Fiscal year 2023: 14.66 million shares | Fiscal year 2022: 14.63 million shares | Fiscal year 2021: 14.44 million shares | Fiscal year 2020: 14.33 million shares | Fiscal year 2019: 14.31 million shares | Fiscal year 2018: 14.21 million shares | Fiscal year 2017: 14.69 million shares | Fiscal year 2016: 14.63 million shares | Fiscal year 2015: 15.04 million shares | Fiscal year 2014: 14.85 million shares | Fiscal year 2013: 14.29 million shares | Fiscal year 2012: 13.87 million shares | Fiscal year 2011: 13.63 million shares | Fiscal year 2010: 13.48 million shares.
- Data sourced from SEC EDGAR public filings as of June 23, 2026.
Last verified: